Compass Financial Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Compass Financial Advisors LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$83.14 - $145.99 $49,884 - $87,594
-600 Reduced 18.44%
2,653 $387,000
Q1 2022

May 05, 2022
SELL
$110.08 - $142.92 $71,772 - $93,183
-652 Reduced 16.7%
3,253 $386,000
Q4 2021

Feb 24, 2022
BUY
$99.73 - $148.48 $389,445 - $579,814
3,905 New
3,905 $538,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Compass Financial Advisors LLC Portfolio

Follow Compass Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compass Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Compass Financial Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email